scholarly article | Q13442814 |
P356 | DOI | 10.1074/JBC.M207577200 |
P8608 | Fatcat ID | release_l6u5sw7wrjdjjnazh2alp6td54 |
P3181 | OpenCitations bibliographic resource ID | 601267 |
P698 | PubMed publication ID | 12417590 |
P50 | author | Nico Ghilardi | Q47160885 |
P2093 | author name string | Frederic J de Sauvage | |
Austin L Gurney | |||
Ming-Hong Xie | |||
Sudeepta Aggarwal | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | T cell activation | Q14863969 |
interleukins | Q194908 | ||
P304 | page(s) | 1910-4 | |
P577 | publication date | 2003-01-17 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 | |
P478 | volume | 278 |
Q97644483 | 11g, a Potent Antifungal Candidate, Enhances Candida albicans Immunogenicity by Unmasking β-Glucan in Fungal Cell Wall |
Q64076145 | 2D Visualization of the Psoriasis Transcriptome Fails to Support the Existence of Dual-Secreting IL-17A/IL-22 Th17 T Cells |
Q34865214 | 7α-Hydroxycholesterol Elicits TLR6-Mediated Expression of IL-23 in Monocytic Cells |
Q53087534 | A C-type lectin receptor pathway is responsible for the pathogenesis of acute cyclophosphamide-induced cystitis in mice. |
Q58803375 | A Mechanistic Computational Model Reveals That Plasticity of CD4 T Cell Differentiation Is a Function of Cytokine Composition and Dosage |
Q39632027 | A Naturally Occurring, Soluble Antagonist of Human IL-23 Inhibits the Development and In Vitro Function of Human Th17 Cells |
Q55504448 | A bi-specific inhibitor targeting IL-17A and MMP-9 reduces invasion and motility in MDA-MB-231 cells. |
Q42767100 | A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. |
Q29547855 | A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 |
Q34126219 | A formal analysis of cytokine networks in chronic fatigue syndrome |
Q28270603 | A genome-wide association study identifies IL23R as an inflammatory bowel disease gene |
Q35624686 | A multiscale systems perspective on cancer, immunotherapy, and Interleukin-12 |
Q47657450 | A new class of biologic agents facing the therapeutic paradigm in psoriasis: anti-IL-23 agents. |
Q37249268 | A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. |
Q34394104 | A new phenylpyrazoleanilide, y-320, inhibits interleukin 17 production and ameliorates collagen-induced arthritis in mice and cynomolgus monkeys |
Q42604117 | A novel immunoregulatory function for IL-23: Inhibition of IL-12-dependent IFN-γ production |
Q43535104 | A novel insertion variant of the human IL-23 receptor-alpha chain transcript |
Q33994181 | A novel p40-independent function of IL-12p35 is required for progression and maintenance of herpes stromal keratitis |
Q37019598 | A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy |
Q48025939 | A pathogenic role of IL- 17 at the early stage of corneal allograft rejection |
Q37898704 | A pharmacoeconomic analysis of severe psoriasis therapy: a review of treatment choices and cost efficiency. |
Q37260173 | A protective function for interleukin 17A in T cell-mediated intestinal inflammation |
Q41995656 | A restricted role for TYK2 catalytic activity in human cytokine responses revealed by novel TYK2-selective inhibitors |
Q48023237 | A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis |
Q34135803 | A review of the application of inflammatory biomarkers in epidemiologic cancer research |
Q41845458 | A single intradermal injection of IFN-γ induces an inflammatory state in both non-lesional psoriatic and healthy skin |
Q59340341 | A standardized herbal extract PM014 ameliorates pulmonary fibrosis by suppressing the TGF-β1 pathway |
Q30423922 | A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine. |
Q38170180 | A tale of two cytokines: IL-17 and IL-22 in asthma and infection |
Q50937567 | ATP conditions intestinal epithelial cells to an inflammatory state that promotes components of DC maturation. |
Q45795416 | AZ17: a new bispecific drug targeting IL-6 and IL-23 with potential clinical use--improves psoriasis in a human xenograft transplantation model. |
Q90216608 | Abnormal numbers of CD4+ T lymphocytes and abnormal expression of CD4+ T lymphocyte‑secreted cytokines in patients with immune‑related haemocytopenia |
Q36843812 | Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease |
Q26765767 | Acinetobacter baumannii Infection and IL-17 Mediated Immunity |
Q38877411 | Activation of Myeloid TLR4 Mediates T Lymphocyte Polarization after Traumatic Brain Injury |
Q34358363 | Activation of OX40 Augments Th17 Cytokine Expression and Antigen-Specific Uveitis |
Q41852978 | Adaptive immune response to viral infections in the central nervous system |
Q37350345 | Adenoviral-mediated, intratumor gene transfer of interleukin 23 induces a therapeutic antitumor response |
Q24802970 | Adoptive immunotherapy of cancer with polyclonal, 108-fold hyperexpanded, CD4+ and CD8+ T cells |
Q36116022 | Advances in pharmacotherapy for primary biliary cirrhosis |
Q38193099 | Advances in treating psoriasis |
Q37720742 | Advances in vaccination against Helicobacter pylori |
Q37246355 | Age-related changes in arthritis susceptibility and severity in a murine model of rheumatoid arthritis |
Q48184671 | Amelioration of autoimmunity with an inhibitor selectively targeting all active centres of the immunoproteasome |
Q34461242 | Analytical assessment of interleukin - 23 and -27 cytokines in healthy people and patients with hepatitis C virus infection (genotypes 1 and 3a) |
Q57206559 | Anti-IL-17A Autovaccination Prevents Clinical and Histological Manifestations of Experimental Autoimmune Encephalomyelitis |
Q38339183 | Anti-IL-23 antibody blockade of IL-23/IL-17 pathway attenuates airway obliteration in rat orthotopic tracheal transplantation |
Q50120034 | Anti-IgE and Biologic Approaches for the Treatment of Asthma |
Q64075128 | Anti-TNF Therapy in Spondyloarthritis and Related Diseases, Impact on the Immune System and Prediction of Treatment Responses |
Q37837129 | Anti-cytokine therapies for psoriasis |
Q95319571 | Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses |
Q35637379 | Antigen-specific blocking of CD4-specific immunological synapse formation using BPI and current therapies for autoimmune diseases |
Q48072356 | Antrodia cinnamomea Extract Inhibits Th17 Cell Differentiation and Ameliorates Imiquimod-Induced Psoriasiform Skin Inflammation |
Q99565583 | Aryl Ether-Derived Sphingosine-1-Phosphate Receptor (S1P1) Modulators: Optimization of the PK, PD, and Safety Profiles |
Q36601866 | Association Between Three SNPs and Thromboangiitis Obliterans in Xinjiang Uyghur Population |
Q34213872 | Association analysis of IL-17A and IL-17F polymorphisms in Chinese Han women with breast cancer |
Q41387626 | Association between IL17A/IL17RA Gene Polymorphisms and Susceptibility to Alopecia Areata in the Korean Population |
Q47880901 | Association between SNPs at IL-17A and IL-17F and susceptibility to accelerated silicosis. |
Q42797127 | Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G). |
Q47595534 | Association of interleukin 23 receptor gene polymorphisms (rs10489629, rs7517847) with rheumatoid arthritis in European population: a meta-analysis. |
Q47362251 | Association of interleukin-17A and -17F gene single-nucleotide polymorphisms with autoimmune thyroid diseases. |
Q33280355 | Association of polymorphisms in IL-12/IFN-gamma pathway genes with susceptibility to pulmonary tuberculosis in Indonesia |
Q86958149 | Association with Genetic Variants in the IL-23 and NF-κB Pathways Discriminates between Mild and Severe Psoriasis Skin Disease |
Q37217881 | Barrier immunity and IL-17. |
Q53397201 | Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer's Disease Pathogenesis. |
Q21195672 | Biology of recently discovered cytokines: interleukin-17--a unique inflammatory cytokine with roles in bone biology and arthritis |
Q37039027 | Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo. |
Q49837454 | Blood cytokine concentrations in pediatric patients with anaplastic lymphoma kinase-positive anaplastic large cell lymphoma |
Q37955218 | Briakinumab for the treatment of plaque psoriasis |
Q39150741 | Burkholderia pseudomallei induces IL-23 production in primary human monocytes. |
Q35894777 | Bystander-mediated stimulation of proteolipid protein-specific regulatory T (Treg) cells confers protection against experimental autoimmune encephalomyelitis (EAE) via TGF-β. |
Q37373136 | C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells |
Q40620665 | CCL27: Novel Cytokine with Potential Role in Pathogenesis of Multiple Sclerosis |
Q37286597 | CCR6 is required for IL-23-induced psoriasis-like inflammation in mice |
Q37061386 | CD4 T cells: Balancing the coming and going of autoimmune-mediated inflammation in the CNS. |
Q33584826 | CD4 T-cell expression of IFN-γ and IL-17 in pediatric malarial anemia |
Q36622318 | CD4(+) T-cell subsets and host defense in the lung |
Q38732306 | CD4+ T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm |
Q34927465 | CD4+ Th17 cells discriminate clinical types and constitute a third subset of non Th1, Non Th2 T cells in human leprosy |
Q36528933 | CD4+ memory T cells: functional differentiation and homeostasis |
Q35231921 | CD8+ IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses |
Q36946584 | CXCL12 (SDF-1alpha) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells |
Q36825073 | CXCR4 inhibitor attenuates ovalbumin-induced airway inflammation and hyperresponsiveness by inhibiting Th17 and Tc17 cell immune response |
Q37548220 | Candida albicans airway exposure primes the lung innate immune response against Pseudomonas aeruginosa infection through innate lymphoid cell recruitment and interleukin-22-associated mucosal response |
Q37145684 | Cardiometabolic risk in psoriasis: differential effects of biologic agents |
Q83060208 | Caspase-5 expression is upregulated in lesional psoriatic skin |
Q35026302 | Cause for controversy? Infliximab in the treatment of ulcerative colitis: an update |
Q39241774 | Cellular and Molecular Dynamics of Th17 Differentiation and its Developmental Plasticity in the Intestinal Immune Response |
Q35996521 | Cellular and humoral mechanisms involved in the control of tuberculosis |
Q34028060 | Cellular and molecular basis for the regulation of inflammation by TGF-beta |
Q37847149 | Chlamydophila pneumoniae re-infection triggers the production of IL-17A and IL-17E, important regulators of airway inflammation |
Q35689204 | Chronic exposure to Helicobacter pylori impairs dendritic cell function and inhibits Th1 development |
Q37790958 | Chronic mucocutaneous candidiasis and congenital susceptibility to Candida |
Q33642445 | Cigarette smoke-induced oxidative stress suppresses generation of dendritic cell IL-12 and IL-23 through ERK-dependent pathways |
Q33677718 | Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barré syndrome and downregulated by IVIg treatments. |
Q27022559 | Clinical biomarkers and pathogenic-related cytokines in rheumatoid arthritis |
Q36949978 | Coinfection with the intestinal nematode Heligmosomoides polygyrus markedly reduces hepatic egg-induced immunopathology and proinflammatory cytokines in mouse models of severe schistosomiasis. |
Q37139712 | Combination therapy of lovastatin and rolipram provides neuroprotection and promotes neurorepair in inflammatory demyelination model of multiple sclerosis |
Q54267703 | Combinatorial control of Th17 and Th1 cell functions by genetic variations in genes associated with the interleukin-23 signaling pathway in spondyloarthritis. |
Q64067928 | Combining Understanding of Immunological Mechanisms and Genetic Variants Toward Development of Personalized Medicine for Psoriasis Patients |
Q40054411 | Commercial peptidoglycan preparations are contaminated with superantigen-like activity that stimulates IL-17 production |
Q26779961 | Comparative Immune Response in Children and Adults with H. pylori Infection |
Q45119717 | Complement C5a regulates IL-17 by affecting the crosstalk between DC and gammadelta T cells in CLP-induced sepsis |
Q33936619 | Compromised gastrointestinal integrity in pigtail macaques is associated with increased microbial translocation, immune activation, and IL-17 production in the absence of SIV infection |
Q64996165 | Connection between γδ T-cell- and Adenosine- Mediated Immune Regulation in the Pathogenesis of Experimental Autoimmune Uveitis. |
Q35678887 | Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells |
Q40092005 | Correlation Between the Expression of MicroRNA-301a-3p and the Proportion of Th17 Cells in Patients with Rheumatoid Arthritis |
Q35854365 | Correlation between acute myeloid leukemia and IL-17A, IL-17F, and IL-23R gene polymorphism. |
Q36204121 | Critical involvement of macrophage infiltration in the development of Sjögren's syndrome-associated dry eye. |
Q35005403 | Critical role of IL-17RA in immunopathology of influenza infection |
Q33799144 | Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection |
Q64056525 | Cross-Talk Between Antigen Presenting Cells and T Cells Impacts Intestinal Homeostasis, Bacterial Infections, and Tumorigenesis |
Q45086536 | Crucial role for nuclear factor of activated T cells in T cell receptor-mediated regulation of human interleukin-17. |
Q42821897 | Curcumin induces maturation-arrested dendritic cells that expand regulatory T cellsin vitroandin vivo |
Q90745225 | Current Developments in the Immunology of Psoriasis |
Q37991748 | Current investigational drugs in psoriasis |
Q35606563 | Current status of the immunomodulation and immunomediated therapeutic strategies for multiple sclerosis |
Q36984703 | Current understanding of Pneumocystis immunology |
Q38260780 | Cutting edge: IFN-γR signaling in non-T cell targets regulates T cell-mediated intestinal inflammation through multiple mechanisms |
Q34080154 | Cutting edge: IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL/6-lpr/lpr mice |
Q33740453 | Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. |
Q37776658 | Cytokine Overproduction, T-Cell Activation, and Defective T-Regulatory Functions Promote Nephritis in Systemic Lupus Erythematosus |
Q38067389 | Cytokine control of inflammation and repair in the pathology of multiple sclerosis. |
Q37994612 | Cytokine-based therapy in psoriasis |
Q22306446 | Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity |
Q37751877 | Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances |
Q52664758 | Cytokines in uveitis. |
Q38333262 | Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells |
Q93379581 | Cytokinome of adult-derived human liver stem/progenitor cells: immunological and inflammatory features |
Q89495071 | DGK α and ζ Activities Control TH1 and TH17 Cell Differentiation |
Q35616110 | Decreased Th17 and antigen-specific humoral responses in CX₃ CR1-deficient mice in the collagen-induced arthritis model |
Q34309180 | Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders |
Q45854756 | Decreased interleukin-20 level in patients with systemic sclerosis: are they related with angiogenesis? |
Q35884333 | Dectin-2-dependent host defense in mice infected with serotype 3 Streptococcus pneumoniae |
Q26998296 | Defining the functional states of Th17 cells |
Q35826624 | Dendritic Cell-Induced Th1 and Th17 Cell Differentiation for Cancer Therapy |
Q27003889 | Dendritic cell interactions with Histoplasma and Paracoccidioides |
Q87202108 | Der p1 and Der p2-Specific T Cells Display a Th2, Th17, and Th2/Th17 Phenotype in Atopic Dermatitis |
Q41194989 | Detection of IL-17 and IL-23 in Plasma Samples of Children with Autism |
Q34288251 | Development of a TH17 immune response during the induction of murine syngeneic graft-versus-host disease |
Q79264742 | Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis |
Q36808811 | Development of proteoglycan-induced arthritis is independent of IL-17. |
Q37857328 | Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives |
Q29617131 | Development, cytokine profile and function of human interleukin 17-producing helper T cells |
Q33972053 | Dexamethasone restrains ongoing expression of interleukin-23p19 in peripheral blood-derived human macrophages |
Q61448104 | Dietary Habits and Intestinal Immunity: From Food Intake to CD4 T Cells |
Q62661893 | Difference of interleukin-23 receptor gene haplotype variants in ulcerative colitis compared to Crohn’s disease and psoriasis |
Q36915902 | Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections |
Q53885284 | Differential macrophage expression of IL-12 and IL-23 upon innate immune activation defines rat autoimmune susceptibility. |
Q29614838 | Differentiation of effector CD4 T cell populations (*) |
Q33788735 | Directing traffic: IL-17 and IL-22 coordinate pulmonary immune defense |
Q34236439 | Discovery and mechanism of ustekinumab: a human monoclonal antibody targeting interleukin-12 and interleukin-23 for treatment of immune-mediated disorders |
Q60047543 | Disease Tolerance and Pathogen Resistance Genes May Underlie Persistence and Differential Progression to Chagas Disease Cardiomyopathy |
Q24674584 | Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression |
Q42145907 | Distinct gene-expression profiles associated with the susceptibility of pathogen-specific CD4 T cells to HIV-1 infection. |
Q24304986 | Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells |
Q29614224 | Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation |
Q34450323 | Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae |
Q35141261 | Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. |
Q82930126 | Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells |
Q56981883 | Dynamic interaction between T cell-mediated β-cell damage and β-cell repair in the run up to autoimmune diabetes of the NOD mouse |
Q38940192 | Dynamics of Th17 associating cytokines in Cryptosporidium parvum-infected mice |
Q28076496 | Effect of IL-17 receptor A blockade with brodalumab in inflammatory diseases |
Q80809164 | Effects of IL-23 and IL-27 on osteoblasts and osteoclasts: inhibitory effects on osteoclast differentiation |
Q58749034 | Effects of interleukin-17A in nucleus pulposus cells and its small-molecule inhibitors for intervertebral disc disease |
Q36537915 | Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category |
Q90212429 | Elevated O-GlcNAcylation enhances pro-inflammatory Th17 function by altering the intracellular lipid microenvironment |
Q33416432 | Elevated expression of IL-12 and IL-23 in patients with primary immune thrombocytopenia |
Q54596530 | Elevated interferon gamma expression in the central nervous system of tumour necrosis factor receptor 1-deficient mice with experimental autoimmune encephalomyelitis. |
Q34104703 | Elucidating the chromosome 9 association with AS; CARD9 is a candidate gene |
Q37360656 | Emergence of the Th17 pathway and its role in host defense. |
Q88791834 | Emerging IL-12 family cytokines in the fight against fungal infections |
Q36634244 | Emerging drugs for psoriasis |
Q38616563 | Emerging monoclonal antibodies as targeted innovative therapeutic approaches to asthma. |
Q37730867 | Emerging role of interleukin-22 in autoimmune diseases |
Q37744925 | Emerging roles of T helper subsets in the pathogenesis of asthma |
Q38585850 | Emerging strategies for cancer immunoprevention |
Q24605738 | Emerging therapies for the treatment of psoriasis |
Q28507698 | Enforced expression of GATA3 allows differentiation of IL-17-producing cells, but constrains Th17-mediated pathology |
Q36712402 | Enhanced viral immunoinflammatory lesions in mice lacking IL-23 responses |
Q42832660 | Epidermal phospholipase Cδ1 regulates granulocyte counts and systemic interleukin-17 levels in mice |
Q34126784 | Epinephrine-primed murine bone marrow-derived dendritic cells facilitate production of IL-17A and IL-4 but not IFN-γ by CD4+ T cells. |
Q30853216 | Epithelial IL-23R Signaling Licenses Protective IL-22 Responses in Intestinal Inflammation |
Q35329102 | Estradiol inhibits Th17 cell differentiation through inhibition of RORγT transcription by recruiting the ERα/REA complex to estrogen response elements of the RORγT promoter |
Q42324501 | Ethanol exposure suppresses bone marrow-derived dendritic cell inflammatory responses independent of TLR4 expression |
Q28588354 | Evidence for PI-3K-dependent migration of Th17-polarized cells in response to CCR2 and CCR6 agonists |
Q37316594 | Evidence that cytokines play a role in rheumatoid arthritis |
Q41941686 | Exacerbated egg-induced immunopathology in murine Schistosoma mansoni infection is primarily mediated by IL-17 and restrained by IFN-γ. |
Q51795770 | Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis. |
Q39414999 | Expression of IL-23, VEGF and TLR2/TLR4 on mononuclear cells after exposure to Pseudomonas aeruginosa |
Q80643867 | Expression of Th17 cytokines in skin lesions of patients with psoriasis |
Q34188885 | Expression of interleukin-17 is correlated with interferon-α expression in cutaneous lesions of lupus erythematosus. |
Q30698666 | FcγRIIIa-Syk Co-signal Modulates CD4+ T-cell Response and Up-regulates Toll-like Receptor (TLR) Expression |
Q54453217 | Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. |
Q37374943 | From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited |
Q40619563 | Functional Cooperation between Interleukin-17 and Tumor Necrosis Factor-α Is Mediated by CCAAT/Enhancer-binding Protein Family Members |
Q38138105 | Functional plasticity of Th17 cells: implications in gastrointestinal tract function. |
Q37850400 | Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease |
Q28743977 | Functional studies on the IBD susceptibility gene IL23R implicate reduced receptor function in the protective genetic variant R381Q |
Q35981383 | Fyn promotes Th17 differentiation by regulating the kinetics of RORγt and Foxp3 expression |
Q39991041 | Gait abnormalities and inflammatory cytokines in an autologous nucleus pulposus model of radiculopathy |
Q37463208 | Generation and immunologic functions of Th17 cells in malignant gliomas |
Q34200786 | Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemia |
Q34693337 | Generation of inducible immortalized dendritic cells with proper immune function in vitro and in vivo |
Q24625230 | Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling |
Q91735135 | Genetic and molecular biology of breast cancer among Iranian patients |
Q51029281 | Genetic proof for the transient nature of the Th17 phenotype. |
Q37074271 | Genetic variants associated with Crohn's disease |
Q37841401 | Genetics of ulcerative colitis |
Q36247085 | Getting under the skin: the immunogenetics of psoriasis |
Q35556594 | Ghrelin inhibits the differentiation of T helper 17 cells through mTOR/STAT3 signaling pathway |
Q40642335 | Gingival Toll-like receptor and cytokine messenger RNA levels in equine periodontitis and oral health. |
Q36110545 | Glycosphingolipids mediate pneumocystis cell wall β-glucan activation of the IL-23/IL-17 axis in human dendritic cells |
Q57705930 | Guselkumab, an anti-interleukin-23 monoclonal antibody, for the treatment of moderate to severe plaque-type psoriasis in Japanese patients: Efficacy and safety results from a phase 3, randomized, double-blind, placebo-controlled study |
Q37178385 | HLA-B27 misfolding and spondyloarthropathies |
Q92342000 | Helper T cell differentiation |
Q36228555 | Helper T cell differentiation enters a new era: le roi est mort; vive le roi! |
Q38202009 | Helper T-cell differentiation in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation |
Q90576538 | Hematobin is a novel immunomodulatory protein from the saliva of the horn fly Haematobia irritans that inhibits the inflammatory response in murine macrophages |
Q37424307 | Heme oxygenase-1-transduced bone marrow mesenchymal stem cells in reducing acute rejection and improving small bowel transplantation outcomes in rats |
Q34795426 | Hepatitis B virus induces IL-23 production in antigen presenting cells and causes liver damage via the IL-23/IL-17 axis |
Q33589516 | High gene expression of inflammatory markers and IL-17A correlates with severity of injection site reactions of Atlantic salmon vaccinated with oil-adjuvanted vaccines |
Q38058619 | Hormone and immune system interactions in demyelinating disease |
Q47143948 | Human Adipose-Derived Stem Cells Suppress Elastase-Induced Murine Abdominal Aortic Inflammation and Aneurysm Expansion Through Paracrine Factors |
Q33525560 | Human CD4 memory T cells can become CD4+IL-9+ T cells |
Q24633691 | Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria |
Q34320455 | Human RORγt+ TH17 cells preferentially differentiate from naive FOXP3+Treg in the presence of lineage-specific polarizing factors |
Q37157962 | Human Th17 cells |
Q43156989 | Human alveolar macrophage gene responses to Mycobacterium tuberculosis strains H37Ra and H37Rv |
Q42417394 | Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. |
Q37362590 | IL-10 control of CD11c+ myeloid cells is essential to maintain immune homeostasis in the small and large intestine. |
Q35951805 | IL-12 and IL-23: master regulators of innate and adaptive immunity. |
Q50091570 | IL-12 family members: differential kinetics of their TLR4-mediated induction by Salmonella enteritidis and the impact of IL-10 in bone marrow-derived macrophages |
Q42972111 | IL-12- and IL-23-induced T helper cell subsets: birds of the same feather flock together |
Q37184595 | IL-12R beta 2 promotes the development of CD4+CD25+ regulatory T cells |
Q36034788 | IL-17 Expression in the Time Course of Acute Anti-Thy1 Glomerulonephritis |
Q47774368 | IL-17 and related cytokines involved in systemic sclerosis: Perspectives |
Q34019620 | IL-17 as a future therapeutic target for rheumatoid arthritis |
Q55362292 | IL-17 can be protective or deleterious in murine pneumococcal pneumonia. |
Q37997818 | IL-17 in human asthma |
Q33815790 | IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice |
Q37141196 | IL-17 producing CD4+ T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice |
Q37135557 | IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice |
Q39880454 | IL-17 secreted by tumor reactive T cells induces IL-8 release by human renal cancer cells |
Q38111443 | IL-17 targeted therapies for psoriasis |
Q26996213 | IL-17+Foxp3+ T cells: an intermediate differentiation stage between Th17 cells and regulatory T cells |
Q37858344 | IL-17-expressing cells as a potential therapeutic target for treatment of immunological disorders |
Q37983096 | IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential |
Q43806029 | IL-17: important for host defense, autoimmunity, and allergy? |
Q35958731 | IL-17A G197A gene polymorphism contributes to susceptibility for liver cirrhosis development from patients with chronic hepatitis B infection in Chinese population |
Q57247332 | IL-17A and IL-17F Expression in B Lymphocytes |
Q58096042 | IL-17A contributes to HSV1 infection-induced acute lung injury in a mouse model of pulmonary fibrosis |
Q30435495 | IL-17A controls IL-17F production and maintains blood neutrophil counts in mice |
Q39568602 | IL-17A induces CCL28, supporting the chemotaxis of IgE-secreting B cells |
Q30439191 | IL-17A inhibits the expansion of IL-17A-producing T cells in mice through "short-loop" inhibition via IL-17 receptor |
Q33810455 | IL-17A produced by gammadelta T cells plays a critical role in innate immunity against listeria monocytogenes infection in the liver |
Q35598656 | IL-17A, IL-17F and IL-23R Gene Polymorphisms in Polish Patients with Rheumatoid Arthritis |
Q37066685 | IL-17A-producing T cells are associated with the progression of lung adenocarcinoma |
Q28256188 | IL-17A-producing neutrophil-regulatory Tn lymphocytes |
Q34038176 | IL-17F gene polymorphism is associated with susceptibility to acute myeloid leukemia |
Q36156848 | IL-17RD (Sef or IL-17RLM) interacts with IL-17 receptor and mediates IL-17 signaling. |
Q45408345 | IL-18, but not IL-12, is required for optimal cytokine production by influenza virus-specific CD8+ T cells |
Q46546464 | IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo |
Q35928387 | IL-22 Protects Against Liver Pathology and Lethality of an Experimental Blood-Stage Malaria Infection |
Q39032463 | IL-23 Blockade for Crohn s disease: next generation of anti-cytokine therapy |
Q39649114 | IL-23 Is Essential for the Development of Elastase-Induced Pulmonary Inflammation and Emphysema |
Q58518610 | IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge |
Q50055568 | IL-23 and IL-27 Levels in Serum are Associated with the Process and the Recovery of Guillain-Barré Syndrome |
Q41674783 | IL-23 and Th17 Disease in Inflammatory Arthritis |
Q37349727 | IL-23 and Th17 cytokines in intestinal homeostasis |
Q35952109 | IL-23 dampens the allergic response to Cryptococcus neoformans through IL-17-independent and -dependent mechanisms |
Q29547525 | IL-23 drives a pathogenic T cell population that induces autoimmune inflammation |
Q24294661 | IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats |
Q34521302 | IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6 |
Q24338636 | IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production |
Q33740448 | IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice |
Q24308711 | IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12 |
Q34572769 | IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. |
Q28239522 | IL-23 promotes tumour incidence and growth |
Q38730199 | IL-23 secreted by bronchial epithelial cells contributes to allergic sensitization in asthma model: role of IL-23 secreted by bronchial epithelial cells |
Q90592153 | IL-23 signaling regulation of pro-inflammatory T-cell migration uncovered by phosphoproteomics |
Q34577866 | IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis |
Q34596743 | IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection |
Q51028315 | IL-23-dependent and -independent enhancement pathways of IL-17A production by lactic acid. |
Q84101581 | IL-23-driven encephalo-tropism and Th17 polarization during CNS-inflammation in vivo |
Q80505120 | IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa |
Q33907311 | IL-23/IL-27 Ratio in Peripheral Blood of Patients with Breast Cancer |
Q28282812 | IL-23: changing the verdict on IL-12 function in inflammation and autoimmunity |
Q38040747 | IL-23: one cytokine in control of autoimmunity |
Q40063804 | IL-23R-activated STAT3/STAT4 is essential for Th1/Th17-mediated CNS autoimmunity |
Q38729193 | IL-35 Suppresses Lipopolysaccharide-Induced Airway Eosinophilia in EBI3-Deficient Mice. |
Q34003280 | IL-6 as a druggable target in psoriasis: focus on pustular variants |
Q84593093 | IL-6 blockade preferentially inhibits Th17 differentiation in collagen-induced arthritis |
Q29614839 | IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways |
Q37132980 | IL-6 promotes NK cell production of IL-17 during toxoplasmosis |
Q44162764 | IL-6 regulates neutrophil microabscess formation in IL-17A-driven psoriasiform lesions |
Q48275402 | IL17A and IL23R gene polymorphisms affect the clinical features and prognosis of patients with multiple myeloma. |
Q42280446 | IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection |
Q31036486 | IRAK-2 regulates IL-1-mediated pathogenic Th17 cell development in helminthic infection |
Q36882237 | IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses |
Q38468925 | Identification of Acvr2a as a Th17 cell-specific gene induced during Th17 differentiation |
Q42170048 | Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cells |
Q24296262 | Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F |
Q51757389 | Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population. |
Q37267375 | Immune defence mechanisms and immunoenhancement strategies in oropharyngeal candidiasis |
Q38137189 | Immune regulation of bone loss by Th17 cells in oestrogen-deficient osteoporosis |
Q45174642 | Immunization with Bivalent Flagellin Protects Mice against Fatal Pseudomonas aeruginosa Pneumonia. |
Q33911650 | Immuno-modulatory activity of Ganoderma lucidum-derived polysacharide on human monocytoid dendritic cells pulsed with Der p 1 allergen |
Q35140973 | Immunodeficiency lentiviral infections in natural and non-natural hosts |
Q37315226 | Immunologic and therapeutic synergy of IL-27 and IL-2: enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow |
Q37802002 | Immunological aspect of cardiac remodeling: T lymphocyte subsets in inflammation-mediated cardiac fibrosis |
Q36993451 | Immunological decision-making: how does the immune system decide to mount a helper T-cell response? |
Q37224656 | Immunology and oxidative stress in multiple sclerosis: clinical and basic approach. |
Q34022013 | Immunomodulatory Effects of dsRNA and Its Potential as Vaccine Adjuvant |
Q80505165 | Immunopathogenesis of inflammatory bowel disease |
Q37982064 | Immunopathological roles of cytokines, chemokines, signaling molecules, and pattern-recognition receptors in systemic lupus erythematosus |
Q38959155 | Immunopathology alters Th17 cell glucocorticoid sensitivity |
Q34932088 | Immunoregulatory cytokines are associated with protection from immunopathology following Mycobacterium avium subspecies paratuberculosis infection in red deer |
Q37328591 | In vitro assays of allosensitization |
Q35783661 | In vivo priming of IL-17(+) uveitogenic T cells is enhanced by Toll ligand receptor (TLR)2 and TLR4 agonists via γδ T cell activation |
Q51040346 | Increased IL-17 production by peripheral T helper cells after tumour necrosis factor blockade in rheumatoid arthritis is accompanied by inhibition of migration-associated chemokine receptor expression. |
Q79782031 | Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women |
Q36481651 | Increased circulating interleukin (IL)-23 in children with malarial anemia: in vivo and in vitro relationship with co-regulatory cytokines IL-12 and IL-10 |
Q33644230 | Increased expression of CD25, CD83, and CD86, and secretion of IL-12, IL-23, and IL-10 by human dendritic cells incubated in the presence of Toll-like receptor 2 ligands and Giardia duodenalis |
Q24676186 | Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris |
Q82663765 | Increased plasma levels of IL-21 and IL-23 in spondyloarthritis are not associated with clinical and MRI findings |
Q34484151 | Increased pulmonary tumor necrosis factor alpha, interleukin-6 (IL-6), and IL-17A responses compensate for decreased gamma interferon production in anti-IL-12 autovaccine-treated, Mycobacterium bovis BCG-vaccinated mice |
Q37318879 | Indoles mitigate the development of experimental autoimmune encephalomyelitis by induction of reciprocal differentiation of regulatory T cells and Th17 cells |
Q37179608 | Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis |
Q28585931 | Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1 |
Q37311131 | Induction, function and regulation of IL-17-producing T cells |
Q48055540 | Induction, regulation and physiological role of IL-17 secreting helper T-cells isolated from PBMC, thymus, and lung lymphocytes of young pigs |
Q37883443 | Inflamed gut mucosa: downstream of interleukin-10. |
Q42104777 | Inflammatory Th17 Cells Express Integrin αvβ3 for Pathogenic Function |
Q37354747 | Inflammatory cytokines in pediatric obstructive sleep apnea |
Q27005445 | Inflammatory pathways of importance for management of inflammatory bowel disease |
Q33911969 | Inflammatory skin disease in K5.hTGF-beta1 transgenic mice is not dependent on the IL-23/Th17 inflammatory pathway |
Q84942990 | Influence of IL17A polymorphisms (rs2275913 and rs3748067) on the susceptibility to ulcerative colitis |
Q34349990 | Influence of IL17A polymorphisms on the aberrant methylation of DAPK and CDH1 in non-cancerous gastric mucosa |
Q27304398 | Inhibition of Granulomatous Inflammation and Prophylactic Treatment of Schistosomiasis with a Combination of Edelfosine and Praziquantel |
Q45980367 | Inhibition of connective tissue growth factor ameliorates disease in a murine model of rheumatoid arthritis. |
Q33608575 | Innate IL-17-producing cells: the sentinels of the immune system |
Q39902875 | Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease |
Q38916194 | Innate lymphoid cells: models of plasticity for immune homeostasis and rapid responsiveness in protection. |
Q42747718 | Innate-like function of memory Th17 cells for enhancing endotoxin-induced acute lung inflammation through IL-22 |
Q36367126 | Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome |
Q37029422 | Interacting neuroendocrine and innate and acquired immune pathways regulate neutrophil mobilization from bone marrow following hemorrhagic shock |
Q38477579 | Interaction network analysis revealed biomarkers in myocardial infarction |
Q37623410 | Interactions between neutrophils, Th17 cells, and chemokines during the initiation of experimental model of multiple sclerosis |
Q30251957 | Interactions of the Immune System with Skin and Bone Tissue in Psoriatic Arthritis: A Comprehensive Review. |
Q39297697 | Interferon-alpha and viral triggers promote functional maturation of human monocyte-derived dendritic cells |
Q38674886 | Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in Cancer |
Q24303817 | Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides |
Q33590409 | Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. |
Q28395500 | Interleukin 12 a key immunoregulatory cytokine in infection applications |
Q37319920 | Interleukin 17 production among patients with American cutaneous leishmaniasis |
Q29547871 | Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages |
Q80102514 | Interleukin 18-independent engagement of interleukin 18 receptor-alpha is required for autoimmune inflammation |
Q34556912 | Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells |
Q80102518 | Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system |
Q37204671 | Interleukin-12 (IL-12), but not IL-23, deficiency ameliorates viral encephalitis without affecting viral control |
Q34248780 | Interleukin-12: an update on its immunological activities, signaling and regulation of gene expression |
Q58411438 | Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis |
Q37728837 | Interleukin-17 and its expanding biological functions. |
Q37552021 | Interleukin-17 and systemic lupus erythematosus: current concepts |
Q37350011 | Interleukin-17 causes neutrophil mediated inflammation in ovalbumin-induced uveitis in DO11.10 mice |
Q38430722 | Interleukin-17 in systemic lupus erythematosus: A comprehensive review |
Q35072565 | Interleukin-17 in various ocular surface inflammatory diseases |
Q50929994 | Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity. |
Q47689166 | Interleukin-17 regulates matrix metalloproteinase activity in human pulmonary tuberculosis. |
Q36835789 | Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy |
Q35675887 | Interleukin-17: the missing link between T-cell accumulation and effector cell actions in rheumatoid arthritis? |
Q37512884 | Interleukin-17A Promotes CD8+ T Cell Cytotoxicity To Facilitate West Nile Virus Clearance |
Q89762380 | Interleukin-17A and Keratinocytes in Psoriasis |
Q36524875 | Interleukin-17A and interleukin-23 in morphea. |
Q35913387 | Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection |
Q37883457 | Interleukin-23 and T helper 17-type responses in intestinal inflammation: from cytokines to T-cell plasticity |
Q37947514 | Interleukin-23 as a potential therapeutic target for rheumatoid arthritis |
Q24677051 | Interleukin-23 drives innate and T cell-mediated intestinal inflammation |
Q89519257 | Interleukin-23 engineering improves CAR T cell function in solid tumors |
Q41960791 | Interleukin-23 is required for development of arthritis in mice vaccinated and challenged with Borrelia species |
Q43276051 | Interleukin-23 receptor gene variants in Hungarian systemic lupus erythematosus patients |
Q54361986 | Interleukin-23 receptor polymorphism as a risk factor for oral cancer susceptibility. |
Q40313360 | Interleukin-23-mediated inflammation in Pseudomonas aeruginosa pulmonary infection. |
Q37404716 | Interleukin-23/Th17 pathways and inflammatory bowel disease |
Q28080986 | Interleukin-23R rs7517847 T/G Polymorphism Contributes to the Risk of Crohn's Disease in Caucasians: A Meta-Analysis |
Q38848936 | Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease: A Critical Review of the Literature |
Q26829619 | Interleukin-35: Expanding Its Job Profile |
Q37073886 | Interleukin-35: odd one out or part of the family? |
Q37273910 | Interleukins 17 and 23 influence the host response to Histoplasma capsulatum |
Q29618163 | Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells |
Q37773302 | Interleukins and cancer immunotherapy. |
Q37276852 | Interplay between effector Th17 and regulatory T cells |
Q35714248 | Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis |
Q36572940 | Intersection of population variation and autoimmunity genetics in human T cell activation |
Q55259683 | Intraperitoneal administration of the anti-IL-23 antibody prevents the establishment of intestinal nematodes in mice. |
Q37159061 | Invariant NKT cells inhibit development of the Th17 lineage |
Q37421251 | Investigating the role of the interleukin-23/-17A axis in rheumatoid arthritis |
Q33455780 | Isolation of Mycobacterium avium subspecies paratuberculosis reactive CD4 T cells from intestinal biopsies of Crohn's disease patients |
Q61649471 | JAK/STAT/PKCδ molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis |
Q35046775 | Jagged-1 signaling suppresses the IL-6 and TGF-β treatment-induced Th17 cell differentiation via the reduction of RORγt/IL-17A/IL-17F/IL-23a/IL-12rb1 |
Q37346779 | Keratinocytes contribute intrinsically to psoriasis upon loss of Tnip1 function. |
Q47692110 | Kynurenic acid downregulates IL-17/1L-23 axis in vitro |
Q53523235 | Lack of association between interleukin 23 receptor gene polymorphisms and rheumatoid arthritis susceptibility. |
Q39265291 | Late developmental plasticity in the T helper 17 lineage |
Q35976768 | Leprosy Reactions Show Increased Th17 Cell Activity and Reduced FOXP3+ Tregs with Concomitant Decrease in TGF-β and Increase in IL-6 |
Q34489206 | Lineage-specific Effects of 1,25-Dihydroxyvitamin D3 on the Development of Effector CD4 T Cells |
Q34490941 | Lipocalin 2 regulates inflammation during pulmonary mycobacterial infections. |
Q47349998 | Live Attenuated Leishmania donovani Centrin Gene-Deleted Parasites Induce IL-23-Dependent IL-17-Protective Immune Response against Visceral Leishmaniasis in a Murine Model |
Q37785522 | Liver ischemia/reperfusion injury: Processes in inflammatory networks-A review |
Q34350569 | Loss and dysregulation of Th17 cells during HIV infection |
Q59090565 | Macrophage migration inhibitory factor stimulates interleukin-17 expression and production in lymph node cells |
Q33613852 | Major secretory antigens of the helminth Fasciola hepatica activate a suppressive dendritic cell phenotype that attenuates Th17 cells but fails to activate Th2 immune responses |
Q36468059 | Mammalian gut immunity. |
Q53828883 | Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition. |
Q46262713 | Marked diversity of IL23R gene haplotype variants in rheumatoid arthritis comparing with Crohn's disease and ankylosing spondylitis |
Q41891115 | Marked induction of c-Maf protein during Th17 cell differentiation and its implication in memory Th cell development |
Q37372628 | Massive but selective cytokine dysregulation in the colon of IL-10-/- mice revealed by multiplex analysis |
Q34678846 | Mechanisms by which chronic ethanol feeding limits the ability of dendritic cells to stimulate T-cell proliferation |
Q91894657 | Mesenchymal Stem Cells Alleviate Moderate-to-Severe Psoriasis by Reducing the Production of Type I Interferon (IFN-I) by Plasmacytoid Dendritic Cells (pDCs) |
Q51704302 | Mesenchymal stem cells improve the outcomes of liver recipients via regulating CD4+ T helper cytokines in rats. |
Q86530888 | Mesenchymal stem cells inhibit Th17 cells differentiation via IFN-γ-mediated SOCS3 activation |
Q46774147 | Methanolic extract of Origanum vulgare ameliorates type 1 diabetes through antioxidant, anti-inflammatory and anti-apoptotic activity. |
Q37172065 | MicroRNA-155 confers encephalogenic potential to Th17 cells by promoting effector gene expression |
Q36839871 | Microbial-induced Th17: superhero or supervillain? |
Q59795977 | Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression |
Q92440328 | Midkine level may be used as a noninvasive biomarker in Crohn’s disease |
Q37331068 | Modulation of cytokines and transcription factors (T-Bet and GATA3) in CD4 enriched cervical cells of Chlamydia trachomatis infected fertile and infertile women upon stimulation with chlamydial inclusion membrane proteins B and C. |
Q34169114 | Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550). |
Q37873404 | Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily |
Q42589687 | Molecular mechanisms of mouse skin tumor promotion |
Q34409404 | Monoclonal antibodies in multiple sclerosis treatment: current and future steps |
Q33728334 | More stories on Th17 cells |
Q27011014 | Multiple sclerosis: the role of cytokines in pathogenesis and in therapies |
Q35880106 | Mutated major histocompatibility complex class II transactivator up-regulates interleukin-33-dependent differentiation of Th2 subset through Nod2 binding for NLR (NOD-like receptor) signaling initiation |
Q36598193 | MyD88 is essential to sustain mTOR activation necessary to promote T helper 17 cell proliferation by linking IL-1 and IL-23 signaling |
Q37256545 | Mycobacterium avium subsp. paratuberculosis fibronectin attachment protein activates dendritic cells and induces a Th1 polarization |
Q43106558 | Mycophenolic acid suppresses granulopoiesis by inhibition of interleukin-17 production |
Q64075903 | NCR group 3 innate lymphoid cells orchestrate IL-23/IL-17 axis to promote hepatocellular carcinoma development |
Q24316237 | Negative regulation of IL-17 production by OX40/OX40L interaction |
Q37067780 | Negative regulation of Th17 responses |
Q41484934 | Neutralization of Human Interleukin 23 by Multivalent Nanobodies Explained by the Structure of Cytokine-Nanobody Complex |
Q79236402 | Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis |
Q35166622 | Neutralization of mouse interleukin-17 bioactivity inhibits corneal allograft rejection |
Q35217462 | Neutralization or absence of the interleukin-23 pathway does not compromise immunity to mycobacterial infection |
Q41389903 | Neutralizing IL-23 is superior to blocking IL-17 in suppressing intestinal inflammation in a spontaneous murine colitis model. |
Q36184396 | New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions |
Q89621631 | New and Emerging Topical Therapies for Psoriasis and Atopic Dermatitis |
Q37001149 | New complexities in helper T cell fate determination and the implications for autoimmune diseases |
Q34175958 | New insights into T cell biology and T cell-directed therapy for autoimmunity, inflammation, and immunosuppression |
Q37361936 | New insights into the roles of dendritic cells in intestinal immunity and tolerance |
Q37846678 | New interleukin-23 pathway inhibitors in dermatology: ustekinumab, briakinumab, and secukinumab |
Q34666072 | New players in the cytokine orchestra of inflammatory bowel disease |
Q35557349 | No evidence for activation of T(H)1 or T(H)17 pathways in unstimulated peripheral blood mononuclear cells from children with β-cell autoimmunity or T1D. |
Q41175731 | Nocardia farcinica activates human dendritic cells and induces secretion of interleukin-23 (IL-23) rather than IL-12p70. |
Q27660136 | Noncanonical conformation of CDR L1 in the anti-IL-23 antibody CNTO4088 |
Q35107889 | Novel IL-12 family members shed light on the orchestration of Th1 responses |
Q37755334 | Novel gene therapeutic strategies for the induction of tolerance in cornea transplantation |
Q53295620 | Novel interactions of a microbial superantigen with TLR2 and TLR4 differentially regulate IL-17 and Th17-associated cytokines. |
Q35368022 | Nucleosides from Phlebotomus papatasi salivary gland ameliorate murine collagen-induced arthritis by impairing dendritic cell functions. |
Q96950815 | One road to the TH17 pathway: how TH1 led to TH17 (and vice versa), and first came last |
Q45899456 | Optimization of human Th17 cell differentiation in vitro: evaluating different polarizing factors. |
Q33681689 | Overexpression of interleukin-23 and interleukin-17 in the lesion of pemphigus vulgaris: a preliminary study |
Q37135491 | P2 purinergic receptor modulation of cytokine production |
Q36043641 | PGE2 Elevates IL-23 Production in Human Dendritic Cells via a cAMP Dependent Pathway |
Q33591700 | PIF* promotes brain re-myelination locally while regulating systemic inflammation- clinically relevant multiple sclerosis M.smegmatis model |
Q52597639 | PKCδ-Mediated Nox2 Activation Promotes Fluid-Phase Pinocytosis of Antigens by Immature Dendritic Cells. |
Q37231755 | PPAR Regulation of Inflammatory Signaling in CNS Diseases |
Q46744291 | Paediatric-onset psoriasis is associated with ERAP1 and IL23R loci, LCE3C_LCE3B deletion and HLA-C*06. |
Q37360652 | Pathogenesis of myocarditis and dilated cardiomyopathy |
Q96134668 | Pathogenesis of psoriasis in the "omic" era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances |
Q34998903 | Pathological role of interleukin-17 in poly I:C-induced hepatitis |
Q33552805 | Periplocoside A prevents experimental autoimmune encephalomyelitis by suppressing IL-17 production and inhibits differentiation of Th17 cells |
Q42378984 | Phage-assisted continuous evolution of proteases with altered substrate specificity |
Q29619323 | Phenotypic and functional features of human Th17 cells |
Q38129871 | Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases |
Q37984817 | Pivotal roles of the interleukin-23/T helper 17 cell axis in hepatitis B. |
Q34300986 | Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection. |
Q38729774 | Platelet-activating factor induces Th17 cell differentiation |
Q54404825 | Polymorphisms of the IL23R gene are associated with psoriasis but not with immunoglobulin A nephropathy in a Hungarian population. |
Q34376236 | Positive and Negative Regulation of Th17 Cell Differentiation: Evaluating The Impact of RORC2. |
Q33942532 | Potent intestinal Th17 priming through peripheral lipopolysaccharide-based immunization |
Q49043582 | Potential role of Th17 cells in the pathogenesis of adult-onset Still's disease |
Q26863295 | Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity |
Q37630095 | Precarious balance: Th17 cells in host defense. |
Q42000043 | Preparation, crystallization and preliminary X-ray diffraction studies of the glycosylated form of human interleukin-23. |
Q34488588 | Preventative role of interleukin-17 producing regulatory T helper type 17 (Treg 17) cells in type 1 diabetes in non-obese diabetic mice. |
Q54390436 | Primary biliary cholangitis: new treatments for an old disease. |
Q36580442 | Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques. |
Q48119915 | Proinflammatory Cytokine IL-17 Shows a Significant Association with Helicobacter pylori Infection and Disease Severity |
Q34181228 | Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases |
Q43162277 | Prolonged ovalbumin challenge facilitates Th17 polarization in sensitized mice |
Q37002699 | Prophylactic and therapeutic suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor |
Q37207581 | Prospects for use of interleukin-12 as a mucosal adjuvant for vaccination of humans to protect against respiratory pneumococcal infection. |
Q36948594 | Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion |
Q38906013 | Protease-activated Receptor 1 Plays a Proinflammatory Role in Colitis by Promoting Th17-related Immunity. |
Q36247264 | Protection against Th17 cells differentiation by an interleukin-23 receptor cytokine-binding homology region |
Q36481763 | Protective immune mechanisms in helminth infection |
Q34306734 | Protective role of 5-lipoxigenase during Leishmania infantum infection is associated with Th17 subset |
Q40387405 | Protective role of naturally occurring interleukin-17A-producing γδ T cells in the lung at the early stage of systemic candidiasis in mice |
Q36921661 | Psoriasis and psoriatic arthritis: separate or one and the same? |
Q36917184 | Psoriasis: evolution of pathogenic concepts and new therapies through phases of translational research |
Q47724381 | Psoriasis: from Pathogenesis to Targeted Therapies. |
Q36648696 | Psoriasis: genetic associations and immune system changes. |
Q34033850 | Pulmonary interleukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs |
Q27026785 | Putting together the psoriasis puzzle: an update on developing targeted therapies |
Q34660473 | RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. |
Q37042876 | Rapid αβ T-cell responses orchestrate innate immunity in response to Staphylococcal enterotoxin A. |
Q24626339 | Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells |
Q34327203 | Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities |
Q27860460 | Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells |
Q37373067 | Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease |
Q39770778 | Reduced TCR-dependent activation through citrullination of a T-cell epitope enhances Th17 development by disruption of the STAT3/5 balance |
Q37348457 | Regulation and function of proinflammatory TH17 cells |
Q37128687 | Regulation of FoxP3 regulatory T cells and Th17 cells by retinoids |
Q26799975 | Regulation of IL-17 in autoimmune diseases by transcriptional factors and microRNAs |
Q42214713 | Regulation of IL-17A expression in mice following subacute ozone exposure |
Q33755232 | Regulation of TH17 Cells and Associated Cytokines in Wound Healing, Tissue Regeneration, and Carcinogenesis |
Q34645439 | Regulation of Th1/Th17 cytokines and IDO gene expression by inhibition of calpain in PBMCs from MS patients |
Q37262374 | Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK. |
Q37795583 | Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27. |
Q42129243 | Regulation of defense responses against protozoan infection by interleukin-27 and related cytokines |
Q54346247 | Regulation of the development of acute hepatitis by IL-23 through IL-22 and IL-17 production. |
Q46226178 | Regulatory T cells control VEGF-dependent skin inflammation |
Q37550813 | Regulatory T cells dampen pulmonary inflammation and lung injury in an animal model of pneumocystis pneumonia |
Q41157946 | Regulatory T cells prevent inducible BALT formation by dampening neutrophilic inflammation. |
Q37021703 | Regulatory T cells vs Th17: differentiation of Th17 versus Treg, are the mutually exclusive? |
Q36518989 | Regulatory effects of C5a on IL-17A, IL-17F, and IL-23 |
Q37086693 | Regulatory mechanisms of helper T cell differentiation: new lessons learned from interleukin 17 family cytokines |
Q39419911 | Relevance of nuclear receptor expression in a Tchreg cell line, HOZOT: RXRα and PPARγ negatively regulate IFN-γ production. |
Q85101810 | Replication of association between interleukin-23 receptor (IL-23R) and its ligand (IL-12B) polymorphisms and psoriasis in the Chinese Han population |
Q26991709 | Review: The interleukin-23/interleukin-17 axis in spondyloarthritis pathogenesis: Th17 and beyond |
Q37736941 | Review: Toll-like receptors and NOD-like receptors in pulmonary antibacterial immunity |
Q37998396 | Revisiting the old link between infection and autoimmune disease with commensals and T helper 17 cells |
Q35981635 | Role of CD25+ dendritic cells in the generation of Th17 autoreactive T cells in autoimmune experimental uveitis |
Q38572497 | Role of Ets Proteins in Development, Differentiation, and Function of T-Cell Subsets |
Q52956094 | Role of IL-12 Receptor β1 in Regulation of T Cell Response by APC in Experimental Autoimmune Encephalomyelitis |
Q38270824 | Role of IL-17 in Glioma Progression |
Q37987880 | Role of IL-17 in psoriasis and psoriatic arthritis |
Q24605366 | Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis |
Q38190986 | Role of IL-23 in the pathogenesis of psoriasis: a novel potential therapeutic target? |
Q36795816 | Role of TH-17 cells in rheumatic and other autoimmune diseases |
Q37172965 | Role of Th1 and Th17 cells in organ-specific autoimmunity. |
Q38237647 | Role of Th17 Cells in the Pathogenesis of Human IBD. |
Q37622866 | Role of Th17 cells and IL-17 in lung transplant rejection |
Q36943381 | Role of cytokine p40 family in multiple sclerosis |
Q37735773 | Role of cytokines as mediators and regulators of microglial activity in inflammatory demyelination of the CNS. |
Q37035188 | Role of cytomegalovirus on the maturation and function of monocyte derived dendritic cells of liver transplant patients |
Q34345547 | Role of heat-stable enterotoxins in the induction of early immune responses in piglets after infection with enterotoxigenic Escherichia coli. |
Q36379352 | Role of infection and antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease |
Q35671653 | Role of interleukin-23 (IL-23) receptor signaling for IL-17 responses in human Lyme disease |
Q33814452 | Role of interleukin-23 circulating levels increase in resected colorectal cancer before and after chemotherapy: preliminary data and future perspectives |
Q38283980 | Role of interleukin-23-dependent antifungal immune responses in dendritic cell-vaccinated mice |
Q49956370 | Role of the T and B lymphocytes in pathogenesis of autoimmune thyroid diseases |
Q80598361 | Role of the cytokine environment and cytokine receptor expression on the generation of functionally distinct dendritic cells from human monocytes |
Q34975829 | Role of transcription factor T-bet expression by CD4+ cells in gastritis due to Helicobacter pylori in mice |
Q38579179 | STAT3: a critical component in the response to Helicobacter pylori infection. |
Q37001334 | STAT4 isoforms differentially regulate Th1 cytokine production and the severity of inflammatory bowel disease |
Q90744992 | STAT4: an immunoregulator contributing to diverse human diseases |
Q48148751 | Safety and efficacy of guselkumab in Japanese patients with moderate-to-severe plaque psoriasis: a randomized, placebo-controlled, ascending-dose study |
Q24547568 | Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells |
Q36212815 | Selective targeting of the IL23 pathway: Generation and characterization of a novel high-affinity humanized anti-IL23A antibody |
Q37411201 | Sequential evolution of IL-17 responses in the early period of allograft rejection. |
Q36891896 | Serum Levels of IL-17 and IL-23 in Patients With Rheumatic Mitral Stenosis |
Q44736570 | Serum concentration of IL-17, IL-23 and TNF-α among patients with chronic spontaneous urticaria: association with disease activity and autologous serum skin test |
Q34235396 | Severe malarial anemia: innate immunity and pathogenesis |
Q42079929 | ShiA abrogates the innate T-cell response to Shigella flexneri infection |
Q50041283 | Shifting the Focus: The Primary Role of IL-23 in Psoriasis and other Inflammatory Disorders. |
Q37367853 | Signal transduction and Th17 cell differentiation |
Q35238480 | Signal transduction pathways and transcriptional regulation in Th17 cell differentiation |
Q36571580 | Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation |
Q35951819 | Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. |
Q34901468 | Silencing IL-23 expression by a small hairpin RNA protects against asthma in mice |
Q28066288 | Smad-dependent mechanisms of inflammatory bone destruction |
Q37696996 | Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse. |
Q42690764 | Specific targeting of the IL-23 receptor, using a novel small peptide noncompetitive antagonist, decreases the inflammatory response |
Q36207257 | Stepwise regulation of TH1 responses in autoimmunity: IL-12-related cytokines and their receptors. |
Q24296669 | Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells |
Q52729761 | Stromal C-type lectin receptor COLEC12 integrates H. pylori, PGE2-EP2/4 axis and innate immunity in gastric diseases. |
Q28068106 | Stromal Fibroblasts in Tertiary Lymphoid Structures: A Novel Target in Chronic Inflammation |
Q34445379 | Structural basis of IL-23 antagonism by an Alphabody protein scaffold |
Q37845252 | Structure and function of interleukin-17 family cytokines. |
Q24648045 | Structure and signalling in the IL-17 receptor family |
Q37051768 | Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy |
Q36911659 | Suppressed Th17 levels correlate with elevated PIAS3, SHP2, and SOCS3 expression in CD4 T cells during acute simian immunodeficiency virus infection |
Q38333473 | Suppression of interleukin-17-producing T-helper 17 cells by retinal pigment epithelial cells |
Q51392642 | Survival time of cardiac allografts prolonged by isogeneic BMT in mice. |
Q36731403 | Susceptibility-associated genetic variation at IL12B enhances Th1 polarization in psoriasis |
Q56880713 | Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17 |
Q35558638 | T cell subsets and their signature cytokines in autoimmune and inflammatory diseases |
Q28395374 | T cell-mediated host immune defenses in the lung |
Q46019531 | T helper 1, 2 and 17 cell subsets in renal transplant patients with delayed graft function. |
Q24609737 | T helper 17 cell heterogeneity and pathogenicity in autoimmune disease |
Q37669790 | T helper 17 cells: discovery, function, and physiological trigger |
Q43457921 | T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis |
Q38609536 | T regulatory (Treg) and T helper 17 (Th17) lymphocytes in thyroid autoimmunity |
Q36765453 | T(H)-17 cells in the circle of immunity and autoimmunity |
Q81381452 | T(H)-17: a giant step from T(H)1 and T(H)2 |
Q33709760 | T-bet and eomesodermin play critical roles in directing T cell differentiation to Th1 versus Th17. |
Q42742129 | T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype. |
Q37273238 | T-bet is essential for encephalitogenicity of both Th1 and Th17 cells |
Q36228767 | T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17 |
Q42110315 | T-bet protects against exacerbation of schistosome egg-induced immunopathology by regulating Th17-mediated inflammation |
Q28589692 | T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORγt |
Q33723154 | T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis |
Q30434324 | T-lineage cells require the thymus but not VDJ recombination to produce IL-17A and regulate granulopoiesis in vivo |
Q34712326 | TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology |
Q24314628 | TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function |
Q28263622 | TGF-beta: a mobile purveyor of immune privilege |
Q37777380 | TGF-β Function in Immune Suppression |
Q39408352 | TGF-β and Th17 Cells Related Injuries in Patients with Sulfur Mustard Exposure. |
Q39266505 | TGF-β-associated miR-27a inhibits dendritic cell-mediated differentiation of Th1 and Th17 cells by TAB3, p38 MAPK, MAP2K4 and MAP2K7. |
Q37467739 | TH17 cells and regulatory T cells in primary immunodeficiency diseases |
Q28276449 | TH17 cells in development: an updated view of their molecular identity and genetic programming |
Q37957689 | TLR-dependent T cell activation in autoimmunity. |
Q46058991 | TLR2-activated human langerhans cells promote Th17 polarization via IL-1beta, TGF-beta and IL-23. |
Q37036047 | TLR9 regulates the mycobacteria-elicited pulmonary granulomatous immune response in mice through DC-derived Notch ligand delta-like 4 |
Q34835806 | TNF-alpha-dependent loss of IKKbeta-deficient myeloid progenitors triggers a cytokine loop culminating in granulocytosis |
Q35537378 | Tamm-Horsfall Protein Regulates Granulopoiesis and Systemic Neutrophil Homeostasis. |
Q36851405 | Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism. |
Q38047820 | Targeting IL-17 and TH17 cells in chronic inflammation |
Q41146021 | Targeting IL-23: insights into the pathogenesis and the treatment of psoriasis |
Q93246335 | Targeting Interleukin-23 in the Treatment of Noninfectious Uveitis |
Q38664951 | Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis |
Q37155421 | Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge |
Q33894387 | Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity |
Q37353985 | Th-17 cell-related cytokines' potential role in the pathogenesis of severe asthma |
Q34038557 | Th1 and Th17 cells: adversaries and collaborators |
Q84373348 | Th1 responses are more susceptible to infliximab-mediated immunosuppression than Th17 responses |
Q37173912 | Th1/Th17 polarization and acquisition of an arthritogenic phenotype in arthritis-susceptible BALB/c, but not in MHC-matched, arthritis-resistant DBA/2 mice |
Q90148050 | Th17 Cells and IL-17 As Novel Immune Targets in Ovarian Cancer Therapy |
Q39118617 | Th17 and regulatory T cells contribute to the in situ immune response in skin lesions of Jorge Lobo's disease |
Q37971256 | Th17 cell cytokine secretion profile in host defense and autoimmunity |
Q37764649 | Th17 cell dynamics in HIV infection |
Q87056606 | Th17 cell expansion in gastric cancer may contribute to cancer development and metastasis |
Q37764651 | Th17 cells and HIV infection |
Q35820734 | Th17 cells in human disease. |
Q38011298 | Th17 cells in immunity to Candida albicans |
Q42976492 | Th17 cells in inflammatory conditions |
Q37049058 | Th17 cells: a new fate for differentiating helper T cells |
Q37217449 | Th17 cells: a new paradigm for cutaneous inflammation |
Q36188911 | Th17 cells: critical mediators of host responses to burn injury and sepsis |
Q33732092 | Th17 cells: effector T cells with inflammatory properties |
Q37173921 | Th17 cells: from precursors to players in inflammation and infection |
Q37298535 | Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. |
Q89777141 | Th17 immune microenvironment in Epstein-Barr virus-negative Hodgkin lymphoma: implications for immunotherapy |
Q36528977 | Th17: the third member of the effector T cell trilogy |
Q27023029 | Th22 cells in allergic disease |
Q37835840 | Th9: a new player in asthma pathogenesis? |
Q36926074 | The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease |
Q40646545 | The Chinese highly pathogenic porcine reproductive and respiratory syndrome virus infection suppresses Th17 cells response in vivo |
Q35582560 | The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses |
Q58803307 | The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond |
Q28300826 | The IL-17 pathway as a major therapeutic target in autoimmune diseases |
Q42825302 | The IL-23/IL-17 axis in inflammation |
Q89999237 | The IL-23/IL-17 pathway in human chronic inflammatory diseases-new insight from genetics and targeted therapies |
Q34969188 | The IL-23/Th17 axis in the immunopathogenesis of psoriasis |
Q41111256 | The IL23 axis plays a key role in the pathogenesis of IBD. |
Q93158307 | The Immunobiology of the Interleukin-12 Family: Room for Discovery |
Q54216565 | The Immunoregulation of Th17 in Host against Intracellular Bacterial Infection. |
Q50175862 | The Interleukin (IL)-23/T helper (Th)17 Axis in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis |
Q37163418 | The Interleukin-23 / Interleukin-17 axis in intestinal inflammation. |
Q26742170 | The Mucosal Immune System and Its Regulation by Autophagy |
Q37276576 | The PD-1/PD-L pathway is up-regulated during IL-12-induced suppression of EAE mediated by IFN-gamma |
Q37557971 | The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part I |
Q47141013 | The Th17 Lineage: From Barrier Surfaces Homeostasis to Autoimmunity, Cancer, and HIV-1 Pathogenesis |
Q35308947 | The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications |
Q38101877 | The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders. |
Q34538706 | The WSX-1 pathway restrains intestinal T-cell immunity |
Q84365020 | The binding activity of Mel-18 at the Il17a promoter is regulated by the integrated signals of the TCR and polarizing cytokines |
Q24614431 | The biological functions of T helper 17 cell effector cytokines in inflammation |
Q53563550 | The clinical role of IL-23p19 in patients with rheumatoid arthritis. |
Q80146459 | The contribution of transcription factor IRF1 to the interferon-gamma-interleukin 12 signaling axis and TH1 versus TH-17 differentiation of CD4+ T cells |
Q24655751 | The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells |
Q37728840 | The cytokine milieu in the interplay of pathogenic Th1/Th17 cells and regulatory T cells in autoimmune disease |
Q36533092 | The dynamics of effector T cells and Foxp3+ regulatory T cells in the promotion and regulation of autoimmune encephalomyelitis |
Q37720058 | The effect of inhaled inactived Mycobacterium phlei as a treatment for asthma |
Q82341302 | The effects of PDL-Ig on collagen-induced arthritis |
Q38186206 | The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. |
Q36104096 | The imbalance between Treg and Th17 cells caused by FTY720 treatment in skin allograft rejection |
Q92404247 | The immunomodulatory role of tumor Syndecan-1 (CD138) on ex vivo tumor microenvironmental CD4+ T cell polarization in inflammatory and non-inflammatory breast cancer patients |
Q36945362 | The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research |
Q42875123 | The increase in intra-macrophage thiols induced by new pro-GSH molecules directs the Th1 skewing in ovalbumin immunized mice. |
Q37103780 | The inflammatory Th 17 subset in immunity against self and non-self antigens |
Q81167109 | The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis |
Q38529525 | The interleukin (IL)-23/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment |
Q36845302 | The interleukin-17 receptor plays a gender-dependent role in host protection against Porphyromonas gingivalis-induced periodontal bone loss |
Q37182464 | The interleukin-23/interleukin-17 axis in spondyloarthritis |
Q37760665 | The multiple faces of CXCL12 (SDF-1alpha) in the regulation of immunity during health and disease |
Q47264616 | The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis |
Q98164823 | The prospect of serum and glucocorticoid-inducible kinase 1 (SGK1) in cancer therapy: a rising star |
Q98564280 | The relationship between preoperative T helper cytokines in the ileal mucosa and the pathogenesis of pouchitis |
Q36832865 | The role of CD4 T cells in the pathogenesis of multiple sclerosis |
Q38976762 | The role of IL 23 in the treatment of psoriasis |
Q38707588 | The role of IL-23 and the IL-23/TH 17 immune axis in the pathogenesis and treatment of psoriasis. |
Q36747499 | The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease |
Q24519770 | The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models |
Q37831821 | The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases |
Q39032617 | The role of Th17-associated cytokines in the pathogenesis of experimental autoimmune uveitis (EAU). |
Q38085723 | The role of cytokines in the pathogenesis of systemic lupus erythematosus - from bench to bedside |
Q38070133 | The role of inflammasome-derived IL-1 in driving IL-17 responses |
Q43933868 | The role of interleukin-17 in murine cytomegalovirus interstitial pneumonia in mice with skin transplants |
Q37829471 | The role of interleukin-17 in the Helicobacter pylori induced infection and immunity |
Q35004526 | The role of interleukin-17 in the pathogenesis of rheumatoid arthritis |
Q34503613 | The role of the immune system in regulating the microbiota |
Q89545824 | The role of the interleukin-23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis |
Q43095069 | The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut. |
Q37995658 | The roles of cells and cytokines in the pathogenesis of psoriasis |
Q39796152 | The secreted form of p28 subunit of interleukin (IL)-27 inhibits biological functions of IL-27 and suppresses anti-allogeneic immune responses |
Q82305649 | The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects |
Q36715471 | The straw that stirs the drink: insight into the pathogenesis of inflammatory bowel disease revealed through the study of microflora-induced inflammation in genetically modified mice |
Q24321297 | The structure of interleukin-23 reveals the molecular basis of p40 subunit sharing with interleukin-12 |
Q34292105 | The tick saliva immunosuppressor, Salp15, contributes to Th17-induced pathology during Experimental Autoimmune Encephalomyelitis |
Q37363065 | The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans |
Q38478216 | The unusual suspects--innate lymphoid cells as novel therapeutic targets in IBD. |
Q40378185 | The use of Th1 cytokines, IL-12 and IL-23, to modulate the immune response raised to a DNA vaccine delivered by gene gun. |
Q38543052 | Therapeutic Potential of IL-17-Mediated Signaling Pathway in Autoimmune Liver Diseases |
Q36958902 | Therapeutic antibodies that target inflammatory cytokines in autoimmune diseases |
Q36993315 | Therapeutic effect of the potent IL-12/IL-23 inhibitor STA-5326 on experimental autoimmune uveoretinitis |
Q34199603 | Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab |
Q41889460 | Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation |
Q92799419 | Time-Dependent Changes in Microglia Transcriptional Networks Following Traumatic Brain Injury |
Q79274214 | Timing of IFN-β Exposure during Human Dendritic Cell Maturation and Naive Th Cell Stimulation Has Contrasting Effects on Th1 Subset Generation: A Role for IFN-β-Mediated Regulation of IL-12 Family Cytokines and IL-18 in Naive Th Cell Differentiation |
Q34375258 | Tissue specific CD4+ T cell priming determines the requirement for interleukin-23 in experimental arthritis |
Q54446553 | Toll-like receptor 6 drives interleukin-17A expression during experimental hypersensitivity pneumonitis. |
Q89762937 | Transcriptional profiling of human macrophages during infection with Bordetella pertussis |
Q36015482 | Transcriptional regulatory networks for CD4 T cell differentiation |
Q41542296 | Transcriptome analysis of rainbow trout in response to non-virion (NV) protein of viral haemorrhagic septicaemia virus (VHSV). |
Q34919012 | Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation |
Q37632469 | Translational mini-review series on Th17 cells: development of mouse and human T helper 17 cells. |
Q28069819 | Treatment challenges in the management of moderate-to-severe plaque psoriasis - role of secukinumab |
Q37462596 | Tristetraprolin down-regulates IL-23 expression in colon cancer cells |
Q35749669 | Tubular cross talk in acute kidney injury: a story of sense and sensibility |
Q38050307 | Tumor necrosis factor-alpha and the cytokine network in psoriasis |
Q43169966 | Unmasking of a protective tumor necrosis factor receptor I-mediated signal in the collagen-induced arthritis model |
Q52839328 | Up-regulated integrinα4β1 on systemic lymphocytes and serum IL-17A in interstitial pneumonia. |
Q34209276 | Update on the genetics and genomics of PBC. |
Q37081486 | Update on the natural history and systemic treatment of psoriasis |
Q33828291 | Upregulation of SOCS3 in lung CD4+ T cells in a mouse model of chronic PA lung infection and suppression of Th17‑mediated neutrophil recruitment in exogenous SOCS3 transfer in vitro |
Q48086737 | Ustekinumab for the treatment of psoriatic arthritis. |
Q24596756 | Ustekinumab in psoriasis immunopathology with emphasis on the Th17-IL23 axis: a primer |
Q91828617 | Ustekinumab in psoriatic arthritis and related phenotypes |
Q36942960 | Ustekinumab in the Treatment of Psoriasis and Psoriatic Arthritis |
Q37303190 | Ustekinumab in the therapy of chronic plaque psoriasis. |
Q28067631 | Ustekinumab in treatment of Crohn's disease: design, development, and potential place in therapy |
Q37523846 | Ustekinumab: a new option in psoriasis therapy |
Q37929165 | Ustekinumab: a review of its use in the management of moderate to severe plaque psoriasis |
Q33916253 | Variation in NOD2 augments Th2- and Th17 responses to myelin basic protein in multiple sclerosis |
Q27486878 | Viral replication and paracrine effects result in distinct, functional responses of dendritic cells following infection with dengue 2 virus |
Q52152068 | Zinc regulates expression of IL-23 p19 mRNA via activation of eIF2α/ATF4 axis in HAPI cells. |
Q53138245 | [Immunopathology of psoriasis: from bench to bedside]. |
Q41831922 | c-Rel is essential for the development of innate and T cell-induced colitis |
Q37012968 | gammadelta T cells: an important source of IL-17. |
Q34434443 | γδ T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. |
Search more.